May 2008
Volume 49, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2008
Effectiveness of Novel Borane-Protected Phosphines as Neuroprotectants in a Rat Optic Nerve Crush Model
Author Affiliations & Notes
  • C. J. Lieven
    Ophthalmology and Visual Sciences, University of Wisconsin, Madison, Wisconsin
  • B. R. Schwechter
    Ophthalmology and Visual Sciences, University of Wisconsin, Madison, Wisconsin
  • M. J. Hoegger
    Ophthalmology and Visual Sciences, University of Wisconsin, Madison, Wisconsin
  • L. A. Levin
    Ophthalmology and Visual Sciences, University of Wisconsin, Madison, Wisconsin
    Ophthalmology, University of Montreal, Montreal, Quebec, Canada
  • Footnotes
    Commercial Relationships  C.J. Lieven, None; B.R. Schwechter, None; M.J. Hoegger, None; L.A. Levin, Wisconsin Alumni Research Foundation, P.
  • Footnotes
    Support  NIH Grant R21EY017970, P30EY016665, RPB
Investigative Ophthalmology & Visual Science May 2008, Vol.49, 2072. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      C. J. Lieven, B. R. Schwechter, M. J. Hoegger, L. A. Levin; Effectiveness of Novel Borane-Protected Phosphines as Neuroprotectants in a Rat Optic Nerve Crush Model. Invest. Ophthalmol. Vis. Sci. 2008;49(13):2072.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Previous work in our laboratory has shown the sulfhydryl reducing compound tris(2-carboxyethyl)phosphine (TCEP) is neuroprotective for retinal ganglion cells (RGCs) after optic nerve crush. We have also developed a novel class of borane-protected substituted phosphines that are reducing agents, and are neuroprotective of RGCs in primary cultures at much lower doses than TCEP (Exp Eye Res 83:1252, 2006). We tested if these compounds would have a similar protective effect after optic nerve crush at lower doses than TCEP.

Methods: : RGCs of 6-10 week old Long-Evans rats were retrogradely labeled with the fluorescent tracer DiI. Seven to 10 days after labeling, the left optic nerve of each rat was crushed with forceps, followed by a 4 µL intravitreal injection of bis(3-propionic acid methyl ester)phenylphosphine borane complex (PB1), (3-propionic acid methyl ester)diphenylphosphine borane complex (PB2), or vehicle alone to final concentrations of 1 nM, 100 nM, or 10 µM. The right eye was used as the control. Nine days after the crush injury, the animals were sacrificed, retinas whole-mounted, and photographed for automated counting with NIH ImageJ software.

Results: : PB2 exhibited significant neuroprotection at a concentration of 10 µM (82.7 ± 4.1% of control eye with PB2 injection vs 63.8 ± 1.5% for vehicle; p = 0.001), corresponding to a rescue of 40 ± 9% of RGCs compared to vehicle alone. PB2 also showed an overall protective effect across treatments by ANOVA (p = 0.007).

Conclusions: : PB2 is neuroprotective of RGCs in an optic nerve crush model at lower concentrations than TCEP. It is unclear if this increase in potency is due to improved cell permeability, better retention within the cell, targeting to an intracellular site, or a combination of these factors.

Keywords: ganglion cells • neuroprotection • oxidation/oxidative or free radical damage 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×